Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Jeffrey Newcorn
Icahn School of Medicine at Mount Sinai, Department: Psychiatry
Should you be removed from our database? Contact us at [email protected]. Read more below.
BioBDx
Payment for services (e.g., consulting fees, honoraria, paid authorship)
Dr. Jeffrey Newcorn receives financial compensation for providing consultation services to several companies which either develop or assess medicines used for the treatment of ADHD. The results of this study could potentially have a financial impact on any of these companies.
Imaging Stimulant and NonStimulant Treatments for ADHD: A Network-Based Approach
The increasing number of medications used to treat ADHD in children raises important questions about the mechanisms by which these different classes of compounds exert their therapeutic effects. This project will establish the therapeutic mechanisms of action of the stimulant methylphenidate and non-stimulant atomoxetine, by answering two key questions: 1) to what extent do effective treatments result in 'normalization' of aberrant brain pathophysiology and/or new 'adaptive' or compensatory changes in neurophysiology - focusing on the interactions between neural networks implicated in ADHD; and 2) what are the common and unique mechanisms of action of the two medications on 'task-positive' and 'task-negative' neural networks?
Filed on March 12, 2013.
Tell us what you know about Jeffrey Newcorn's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Jeffrey Newcorn filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Jeffrey Newcorn | Icahn School of Medicine at Mount Sinai | Conflict of Interest | NLS | $20,000 - $39,999 |
| Jeffrey Newcorn | Icahn School of Medicine at Mount Sinai | Conflict of Interest | Ironshore | $10,000 - $19,999 |
| Jeffrey Newcorn | Icahn School of Medicine at Mount Sinai | Conflict of Interest | Shire | $5,000 - $9,999 |
| Jeffrey Newcorn | Icahn School of Medicine at Mount Sinai | Conflict of Interest | Shire | $5,000 - $9,999 |
| Jeffrey Newcorn | Icahn School of Medicine at Mount Sinai | Conflict of Interest | Sunovian Pharmaceuticals Inc. | $5,000 - $9,999 |
| Jeffrey Newcorn | Icahn School of Medicine at Mount Sinai | Conflict of Interest | Sunovion Pharmaceuticals | $5,000 - $9,999 |
| Jeffrey Newcorn | Icahn School of Medicine at Mount Sinai | Conflict of Interest | Alcobra Ltd. | $5,000 - $9,999 |
| Jeffrey Newcorn | Icahn School of Medicine at Mount Sinai | Conflict of Interest | Shire Pharmaceuticals | $5,000 - $9,999 |
| Jeffrey Newcorn | Icahn School of Medicine at Mount Sinai | Conflict of Interest | Alcobra Ltd | $0 - $4,999 |
| Jeffrey Newcorn | Icahn School of Medicine at Mount Sinai | Conflict of Interest | Enzymotec | $0 - $4,999 |
| Jeffrey Newcorn | Icahn School of Medicine at Mount Sinai | Conflict of Interest | GencoSciences LLC | $0 - $4,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.